investorscraft@gmail.com

Stock Analysis & ValuationAclarion, Inc. (ACONW)

Professional Stock Screener
Previous Close
$0.04
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formula219217.32610633114

Company Information

951 Mariners Island Boulevard
Broomfield, CA 94404
United States
Phone: 650-241-1741
Industry: Medical - Healthcare Information Services
Sector: Healthcare
CEO: Brent Ness
Full Time Employees: 5

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

HomeMenuAccount